CINECA IRIS Institutional Research Information System

D'ALESSANDRO, MIRIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.017
AS - Asia 757
EU - Europa 563
Continente sconosciuto - Info sul continente non disponibili 243
SA - Sud America 39
AF - Africa 11
OC - Oceania 3
Totale 2.633
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 925
IT - Italia 405
BD - Bangladesh 384
CN - Cina 111
SG - Singapore 96
HK - Hong Kong 87
FR - Francia 47
CA - Canada 38
VN - Vietnam 37
DE - Germania 33
BR - Brasile 26
PL - Polonia 20
GB - Regno Unito 17
NL - Olanda 15
MX - Messico 10
CR - Costa Rica 9
HN - Honduras 7
IN - India 7
JM - Giamaica 7
NI - Nicaragua 7
KR - Corea 5
AR - Argentina 4
ES - Italia 4
GT - Guatemala 4
ID - Indonesia 4
TR - Turchia 4
AU - Australia 3
BE - Belgio 3
EC - Ecuador 3
IE - Irlanda 3
IQ - Iraq 3
SA - Arabia Saudita 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
AT - Austria 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CL - Cile 2
CO - Colombia 2
DZ - Algeria 2
JP - Giappone 2
KE - Kenya 2
KZ - Kazakistan 2
LT - Lituania 2
MA - Marocco 2
PR - Porto Rico 2
RS - Serbia 2
TH - Thailandia 2
UA - Ucraina 2
ZA - Sudafrica 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CY - Cipro 1
CZ - Repubblica Ceca 1
GY - Guiana 1
HR - Croazia 1
KH - Cambogia 1
MG - Madagascar 1
MN - Mongolia 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
QA - Qatar 1
TN - Tunisia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 2.390
Salva come PNG Salva come JPEG
Città #
San Jose 205
New York 183
Ashburn 96
Hong Kong 87
Beijing 61
Singapore 49
Rome 43
Los Angeles 42
Santa Clara 40
Milan 39
Buffalo 36
Naples 28
Frankfurt am Main 27
Hillsboro 18
Toronto 18
Turin 14
Bologna 13
Florence 13
Warsaw 13
Vigonza 12
Chicago 11
Montreal 11
Hanoi 10
Ho Chi Minh City 10
Dallas 9
Rimini 9
Charlotte 8
Genoa 8
Mexico City 8
San José 8
Brescia 7
Catania 7
Palermo 7
Bari 6
Managua 6
Pasadena 6
Venice 6
San Diego 5
Seattle 5
Seoul 5
Cagliari 4
Figino 4
Fort Worth 4
Guatemala City 4
Iesi 4
Mumbai 4
Orem 4
Reston 4
San Mauro Pascoli 4
Tampa 4
Verona 4
Amsterdam 3
Atlanta 3
Baghdad 3
Council Bluffs 3
Da Nang 3
Denver 3
Dublin 3
Houston 3
Kingston 3
London 3
Padua 3
Pescara 3
Philadelphia 3
Phoenix 3
Port of Spain 3
Ravenna 3
Riyadh 3
Thái Nguyên 3
Wilmington 3
Wroclaw 3
Alexandria 2
Ancona 2
Arezzo 2
Barletta 2
Bergamo 2
Brugnera 2
Brussels 2
Calgary 2
Casarsa della Delizia 2
Cerdanyola del Vallès 2
Chennai 2
City of London 2
El Progreso 2
Greenville 2
Guayaquil 2
Hackney 2
Jacksonville 2
Jakarta 2
Las Vegas 2
Limburg an der Lahn 2
Madrid 2
Martina Franca 2
Modena 2
Newark 2
Penne 2
Pisa 2
Rocca d'Evandro 2
Rotterdam 2
San Salvador 2
Totale 1.351
Salva come PNG Salva come JPEG
Nome #
Hypercalciuria in Sarcoidosis: A Specific Biomarker With Clinical Utility 62
Evaluation of short and long-term laboratory and instrumental findings in COVID-19 patients hospitalized in Tuscany 61
BAL Proteomic Signature of Lung Adenocarcinoma in IPF Patients and Its Transposition in Serum Samples for Less Invasive Diagnostic Procedures 60
Efficacy and safety of rituximab and low dosage of glucocorticoids for ANCA associated vasculitis interstitial lung disease: a proof-of-concept study 58
From Prognostic Marker to Therapeutic Agent: The Role of Nitric Oxide in Lung Cancer 54
A Novel Ultrasonographic Anthropometric-Independent Measurement of Median Nerve Swelling in Carpal Tunnel Syndrome: The "Nerve/Tendon Ratio" (NTR) 41
Strain echocardiography is a promising tool for the prognostic assessment of sarcoidosis 38
Evaluation of multiple-flows exhaled nitric oxide and its clinical significance in severe asthmatic patients treated with biologics: a prospective real-life study 37
Adaptive immune system in pulmonary sarcoidosis - comparison of peripheral and alveolar biomarkers 36
Sarcoid Nodule or Lung Cancer? A High-Resolution Computed Tomography-Based Retrospective Study of Pulmonary Nodules in Patients with Sarcoidosis 35
Retrospective Study on the Features and Outcomes of a Tuscany COVID-19 Hospitalized Patients Cohort: Preliminary Results 35
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 33
A Precision Surgery Framework for Lung Resection: Robotic, Video-Assisted, and Open Segmentectomy 30
Whole-genome sequencing reveals host factors underlying critical COVID-19 29
Clinical phenotyping in sarcoidosis management 29
A Comprehensive Review of Sarcoidosis Diagnosis and Monitoring for the Pulmonologist 27
Mepolizumab and Benralizumab in Severe Eosinophilic Asthma: Preliminary Results of a Proteomic Study 26
Assessing Short- and Medium-Term Outcomes of Lung Transplantation in Elderly Recipients: A Comparative Age-Based Analysis 26
The effectiveness of nintedanib in patients with idiopathic pulmonary fibrosis, familial pulmonary fibrosis and progressive fibrosing interstitial lung diseases: a real-world study 25
Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis Patients 25
Efficacy and safety of a step-down regimen of low dosage of glucocorticoids combined with early administration of synthetic or biologic immunosuppressants in anti-synthetase syndrome: A pilot study 25
The Effects of Interstitial Lung Diseases on Alveolar Extracellular Vesicles Profile: A Multicenter Study 25
Galactin-1, 3 and 9: Potential biomarkers in idiopathic pulmonary fibrosis and other interstitial lung diseases 24
Extracellular Vesicles in Pulmonary Fibrosis Models and Biological Fluids of Interstitial Lung Disease Patients: A Scoping Review 24
KL-6 in ANCA-Associated Vasculitis Patients with and without ILD: A Machine Learning Approach 22
Serum CD59: a novel biomarker of idiopathic pulmonary fibrosis? 21
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 21
Uncovering Sex and Gender Differences in Sarcoidosis: A Systematic Review of Current Evidence 21
Tocilizumab Vs Methotrexate in a Cohort of Patients Affected by Active GCA: A Comparative Clinical and Ultrasonographic Study 21
Systematic review and metanalysis of oncomarkers in ipf patients and serial changes of oncomarkers in a prospective italian real-life case series 21
Adding pieces to the puzzle: IL-33 contribution to fibrogenesis in chronic lung allograft dysfunction 20
An explainable model of host genetic interactions linked to COVID-19 severity 20
Efficacy and Safety of Upadacitinib in Rheumatoid Arthritis: Real-Life Experience from a Prospective Longitudinal Multicentric Study 20
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 19
Alveolar nitric oxide is related to periostin levels in idiopathic pulmonary fibrosis 19
Neutrophil-to-lymphocyte ratio in IPF patients: a novel prognostic biomarker? 19
Altered serum concentrations of IL-8, IL-32 and IL-10 in patients with lung impairment 6 months after COVID-19 17
Adhesion molecules and T cell imbalance in severe eosinophilic asthma: Insights from anti-IL-5R treatment 17
Extracellular Vesicle Surface Signatures in IPF Patients: A Multiplex Bead-Based Flow Cytometry Approach 17
Personalized Approach of Severe Eosinophilic Asthma Patients Treated with Mepolizumab and Benralizumab 16
Panel of serum biomarkers for differential diagnosis of idiopathic interstitial lung disease and interstitial lung disease-secondary to systemic autoimmune rheumatic disease 16
A Comprehensive Evaluation of Mepolizumab Effectiveness in a Real-Life Setting 16
Effects of rituximab therapy on B cell differentiation and depletion 16
Online survey on existing sarcoidosis registries and biobanks: An ERN lung initiative 16
Immune-Checkpoint Expression on CD4, CD8 and NK Cells in Blood, Bronchoalveolar Lavage and Lymph Nodes of Sarcoidosis 16
Anti-Cytosolic 5′-Nucleotidase 1A in the Diagnosis of Patients with Suspected Idiopathic Inflammatory Myopathies: An Italian Real-Life, Single-Centre Retrospective Study 16
BAL and serum multiplex lipid profiling in idiopathic pulmonary fibrosis and fibrotic hypersensitivity pneumonitis 16
A multicenter approach to evaluate omalizumab effectiveness in Samter’s triad 15
Diagnostic Value of Krebs von den Lungen (KL-6) for Interstitial Lung Disease: A European Prospective Cohort 15
Peripheral biomarkers' panel for severe COVID-19 patients 15
Prognostic role of KL-6 in SSc-ILD patients with pleuroparenchymal fibroelastosis 15
Beyond inflammation: alarmins as critical drivers of pulmonary fibrosis 15
AB0611 Neutrophil extracellular traps and interstitial lung disease in ANCA-associated vasculitis: a scoping review 15
Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis 15
Real-life comparison between pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis 15
Regulatory T Cells in Severe Persistent Asthma in the Era of Monoclonal Antibodies Target Therapies 15
Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy 14
CD103 Expression on Regulatory and Follicular T Cells in Lymph Nodes, Bronchoalveolar Lavage Fluid and Peripheral Blood of Sarcoidosis Patients 14
Regulatory T Cell Phenotype Related to Cytokine Expression Patterns in Post-COVID-19 Pulmonary Fibrosis and Idiopathic Pulmonary Fibrosis 14
Adiponectin and leptin levels in idiopathic pulmonary fibrosis: A new method for BAL and serum assessment 14
Immunological Similarities and Differences between Post-COVID-19 Lung Sequelae and Idiopathic Pulmonary Fibrosis 14
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 14
A multicenter study of extracellular vesicles profile in bronchoalveolar lavage from patients affected by IPF, HP and sarcoidosis 14
Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis 14
POS0823 KL-6 IN ANCA-ASSOCIATED VASCULITIS PATIENTS WITH AND WITHOUT ILD: A MACHINE LEARNING APPROACH 14
Real-life experience of severe asthma patients on Dupilumab treatment in Pordenone’s Hospital 14
Long-Term Follow-Up of Patients With Idiopathic Pulmonary Fibrosis Treated With Pirfenidone or Nintedanib: A Real-Life Comparison Study 13
Accuracy of power Doppler ultrasonography in the diagnosis and monitoring of idiopathic inflammatory myopathies 13
A real-life experience with ImmunoCAP ISAC: the advantages of a new diagnostic method 13
Natural killer T-cells in asthma pathogenesis and treatment: old problems and future perspectives 13
Donor-Recipient Mismatch in Lung Transplantation: The Role of Graft Sizing in Clinical Outcomes 13
Comparative Serum Protein Profiles in IPF Patients Before and After Nintedanib Therapy 13
Serial autoantibody detection in interstitial lung diseases: should they be repeated at follow-up? 13
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 13
Alveolar nitric oxide as a biomarker of COVID-19 lung sequelae: A pivotal study 12
Immune-Checkpoint expression on CD4, CD8 and NK cells in blood, BAL and lymph nodes of sarcoidosis 12
Common Molecular Pathways Between Post-COVID19 Syndrome and Lung Fibrosis: A Scoping Review 12
Combined Sarcoidosis and Idiopathic Pulmonary Fibrosis (CSIPF): A New Phenotype or a Fortuitous Overlap? Scoping Review and Case Series 12
Alteration of Immune-checkpoint after specific stimulation with CMV antigens in pre-LTx patients 12
The role of bDMARDs in idiopathic inflammatory myopathies: A systematic literature review 12
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 11
Right cardiac involvement in lung diseases: a multimodality approach from diagnosis to prognostication 11
Clinical and molecular characterization of COVID-19 hospitalized patients 11
T helper and T cytotoxic cells subsets in peripheral, alveolar and lymph nodes of sarcoidosis patients 11
Imbalance of Lymphocyte Subsets and CD45RA-Expressing Cells in Intrathoracic Lymph Nodes, Alveolar Compartment and Bloodstream of Pulmonary Sarcoidosis Patients 11
Safety and uptake of solid lipid nanoparticles by airway epithelial cells: an in vitro study 11
Exploring the interaction between fractional exhaled nitric oxide and biologic treatment in severe asthma: a systematic review 10
Nk and t cell immunological signatures in hospitalized patients with covid-19 10
Valutazione prognostica della Siero Amiloide A in pazienti affetti da Fibrosi Polmonare Idiopatica 10
POS0871 diagnostic accuracy og power doppler ultrasonography for the diagnosis of idiopathic inflammmatory myopathies 10
A first update on mapping the human genetic architecture of COVID-19 10
Serum ferritin as a specific biomarker of anti-MDA5-interstitial lung disease: a multicenter, case–control study in observational and validation datasets 10
Effect of Ambulatory Oxygen on the Respiratory Pattern during the 6 Min Walking Test in Patients with Interstitial Lung Diseases 10
The value of urinary calcium as biomarker in chronic sarcoidosis 10
Relapses of idiopathic inflammatory myopathies after vaccination against COVID19: a real-life Italian study 10
The Role of Galectins in Chronic Lung Allograft Dysfunction 10
Benralizumab affects NK cell maturation and proliferation in severe asthmatic patients 10
The effect of anti-IL5 monoclonal antibodies on regulatory and effector T cells in severe eosinophilic asthma 10
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes 10
Bronchoalveolar-Lavage-Derived Fibroblast Cell Line (B-LSDM7) as a new protocol for investigating the mechanisms of idiopathic pulmonary fibrosis 10
Totale 1.945
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.918
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.918
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202513 0 0 0 0 0 0 0 0 3 8 2 0
2025/20262.225 9 3 11 14 5 1 93 465 284 505 390 445
2026/2027395 273 122 0 0 0 0 0 0 0 0 0 0
Totale 2.633